Voloridge Investment Management Portfolio holdings
AUM
$27.1B
1-Year Return
25.54%
This Quarter Return
+4.58%
1 Year Return
+25.54%
3 Year Return
+79.26%
5 Year Return
+135.5%
10 Year Return
+413.11%
AUM
$18.3B
AUM Growth
+$2.74B
(+18%)
Cap. Flow
+$2.24B
Cap. Flow
% of AUM
12.26%
Top 10 Holdings %
Top 10 Hldgs %
8.78%
Holding
1,974
New
365
Increased
607
Reduced
559
Closed
443
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$404M |
| 2 |
Honeywell
HON
|
+$154M |
| 3 |
Snap
SNAP
|
+$123M |
| 4 |
Citigroup
C
|
+$118M |
| 5 |
Mercado Libre
MELI
|
+$112M |
Top Sells
| 1 |
Micron Technology
MU
|
+$161M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$127M |
| 3 |
Verizon
VZ
|
+$121M |
| 4 |
Elevance Health
ELV
|
+$108M |
| 5 |
Freeport-McMoran
FCX
|
+$93.5M |
Sector Composition
| 1 | Technology | 17.97% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Industrials | 13.36% |
| 4 | Financials | 12.69% |
| 5 | Healthcare | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Centrus Energy
LEU
$3.99B
| $533K | ﹤0.01% |
+10,672
| New | +$533K |
|
1402
Mersana Therapeutics
MRSN
$36.7M
| $526K | ﹤0.01% |
3,385
-473
| -12% | -$73.5K |
|
1403
O-I Glass
OI
$1.95B
| $525K | ﹤0.01% |
43,607
-6,608
| -13% | -$79.6K |
|
1404
AXIS Capital
AXS
$7.59B
| $517K | ﹤0.01% |
+9,488
| New | +$517K |
|
1405
Core Laboratories
CLB
$577M
| $517K | ﹤0.01% |
23,183
-37,629
| -62% | -$839K |
|
1406
Dorman Products
DORM
$4.86B
| $507K | ﹤0.01% |
4,483
-6,371
| -59% | -$721K |
|
|
SWTX
1407
DELISTED
SpringWorks Therapeutics
SWTX
| $505K | ﹤0.01% |
8,152
-4,826
| -37% | -$299K |
|
1408
Avista
AVA
$2.94B
| $499K | ﹤0.01% |
11,741
+1,559
| +15% | +$66.3K |
|
1409
Jazz Pharmaceuticals
JAZZ
$7.7B
| $493K | ﹤0.01% |
+3,873
| New | +$493K |
|
1410
Bank OZK
OZK
$5.89B
| $491K | ﹤0.01% |
10,563
-3,197
| -23% | -$149K |
|
1411
TTM Technologies
TTMI
$5.11B
| $489K | ﹤0.01% |
32,827
+22,024
| +204% | +$328K |
|
1412
Eagle Materials
EXP
$7.49B
| $486K | ﹤0.01% |
+2,922
| New | +$486K |
|
1413
Prelude Therapeutics
PRLD
$67.4M
| $486K | ﹤0.01% |
+39,014
| New | +$486K |
|
1414
RLI Corp
RLI
$6.08B
| $476K | ﹤0.01% |
+8,490
| New | +$476K |
|
1415
Bausch Health
BHC
$2.64B
| $473K | ﹤0.01% |
17,137
-418,398
| -96% | -$11.5M |
|
1416
LKQ Corp
LKQ
$8.26B
| $462K | ﹤0.01% |
+7,696
| New | +$462K |
|
1417
Morningstar
MORN
$10.6B
| $460K | ﹤0.01% |
1,346
-5,745
| -81% | -$1.96M |
|
1418
Beazer Homes USA
BZH
$758M
| $457K | ﹤0.01% |
19,674
-64,567
| -77% | -$1.5M |
|
1419
Ginkgo Bioworks
DNA
$609M
| $457K | ﹤0.01% |
+1,376
| New | +$457K |
|
1420
Curtiss-Wright
CW
$18.7B
| $449K | ﹤0.01% |
3,239
-1,535
| -32% | -$213K |
|
1421
Euronet Worldwide
EEFT
$3.57B
| $440K | ﹤0.01% |
3,693
-11,141
| -75% | -$1.33M |
|
1422
ASGN Inc
ASGN
$2.23B
| $437K | ﹤0.01% |
+3,544
| New | +$437K |
|
1423
Regenxbio
RGNX
$483M
| $437K | ﹤0.01% |
13,372
-75,032
| -85% | -$2.45M |
|
1424
Universal Health Services
UHS
$11.8B
| $435K | ﹤0.01% |
+3,354
| New | +$435K |
|
1425
New Jersey Resources
NJR
$4.71B
| $430K | ﹤0.01% |
10,474
-6,806
| -39% | -$279K |
|